Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
批准号:
8224502
负责人:
MATTHEW G DORSEY
金额:
$8.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2016-08-31
中文摘要
描述(申请人提供):疟疾仍然是最重要的全球卫生挑战之一,估计有30亿人面临感染风险,每年导致约2.5亿病例和100万人死亡,其中大部分疾病负担集中在撒哈拉以南非洲。自2005年在乌干达成立以来,美国总统疟疾倡议在扩大已被证明有效的疟疾控制干预措施的覆盖面方面取得了巨大成功。尽管有了这些改善,乌干达的疟疾负担仍然很重,没有明确的证据表明发病率和死亡率有所下降。仍然非常需要系统地评价当前疟疾控制干预措施的有效性,并调查新的干预措施。拟议的计划旨在扩大疾病控制和预防中心的合作机构网络,为目标非洲国家提供研究和技术援助,特别是侧重于推进疟疾控制工作的研究。乌干达疟疾监测项目成立于2001年,目的是建立一个多地点监测系统,监测抗疟疾药物的疗效和安全性、与疟疾有关的发病率和死亡率,并建设以设施为基础的疟疾管理能力,以期在疟疾控制方面取得可持续的进展。作为对这一声明的回应,UMSP提议进行以下四项独立的研究,以帮助指导乌干达的疟疾政策决策:1)我们将使用中断的时间序列研究设计进行干预研究,以检验这样一种假设,即与目前治疗复杂疟疾住院的儿童的做法相比,包括基于实验室的治疗决策、青蒿琥酯静脉注射以及标准化剂量和管理在内的一揽子干预措施将改善患者的预后。2)我们将进行一项临床试验,以评估磺胺多辛-乙胺(SP)对孕妇无症状寄生虫血症的体内清除效果,作为评估SP在妊娠期间歇预防治疗的效果的手段。3)我们将在乌干达多个地点进行随机临床试验,比较蒿甲醚-鲁米芬和双氢青蒿素-哌喹治疗单纯性恶性疟疾的疗效和安全性。4)我们将前瞻性地评估关键疟疾控制干预措施(包括经杀虫剂处理的蚊帐、室内残留喷洒杀虫剂和基于青蒿素的联合疗法)的覆盖率,并在乌干达多个地点衡量疟疾传播、感染和疾病的指标。统计技术将被用来估计控制干预措施复盖水平的变化对我们的结果衡量的影响。
与公共卫生相关:这项提议的目的是进行一系列研究,以评估乌干达目前使用的各种疟疾预防和控制干预措施的效力和效果。预计这些研究的结果将有助于指导疟疾政策决策,并最大限度地发挥疟疾预防和控制干预措施的影响。
英文摘要
DESCRIPTION (provided by applicant): Abstract Malaria remains one of the most important global health challenges, with an estimated 3 billion people at risk of infection, leading to approximately 250 million cases and 1 million deaths each year, with a majority of the disease burden concentrated in sub-Saharan Africa. Since its establishment in Uganda in 2005, the U.S. President's Malaria Initiative has been highly successful in expanding the coverage of proven effective malaria control interventions. Despite these improvements, the burden of malaria remains very high in Uganda with no clear evidence of reductions in morbidity and mortality. There remains a great need to systematically evaluative the effectiveness of current malaria control interventions and investigate new interventions. The proposed program is intended to expand the Centers for Disease Control and Prevention network of collaborating institutes for both research and technical assistance to targeted African countries, with a particular focus on research to advance malaria control efforts. The Uganda Malaria Surveillance Project (UMSP) was established in 2001 with the purpose of creating a multi-site surveillance system for monitoring antimalarial drug efficacy and safety, malaria related morbidity and mortality, and building capacity for facility- based management of malaria with the goal of providing sustainable progress in malaria control. In response to this announcement, UMSP is proposing the following four separate research studies to help guide malaria policy decision making in Uganda: 1) We will perform an intervention study using an interrupted time series study design to test the hypothesis that a package of interventions including laboratory-based treatment decision making, IV artesunate, and standardized dosing and administration will improve patient outcomes compared to current practices for children hospitalized with complicated malaria. 2) We will perform a clinical trial to measure the in vivo efficacy of sulfadoxine-pyrimethamine (SP) for the clearance of asymptomatic parasitemia in pregnant women as a means of evaluating the effectiveness of intermittent preventive therapy with SP in pregnancy. 3) We will perform randomized clinical trials at multiple sites in Uganda to compare the efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria. 4) We will prospectively assess the coverage of key malaria control interventions (including insecticide treated bed nets, indoor residual spraying of insecticide, and artemisinin- based combination therapy) and measure metrics of malaria transmission, infection, and disease at multiple sites in Uganda. Statistical techniques will be used to estimate the impact of changing coverage levels of control interventions on our outcome measures.
PUBLIC HEALTH RELEVANCE: The purpose of this proposal is to conduct a series of research studies to evaluate the efficacy and effectiveness of various malaria prevention and control interventions currently in use in Uganda. It is anticipated that the results of these studies will help guide malaria policy decision making and maximize the impact of malaria prevention and control interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda
-
批准号:10381621
-
项目类别:
-
资助金额:$118.15万
-
财政年份:2020
-
负责人:MATTHEW G DORSEY
-
依托单位:
Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda
-
批准号:10604347
-
项目类别:
-
资助金额:$117.72万
-
财政年份:2020
-
负责人:MATTHEW G DORSEY
-
依托单位:
Training in Malaria Epidemiology, Translational Research, and Implementation Science to Strengthen Malaria Policy and Control in Uganda
-
批准号:10673216
-
项目类别:
-
资助金额:$29.72万
-
财政年份:2017
-
负责人:MATTHEW G DORSEY
-
依托单位:
Training in malaria surveillance, epidemiology and implementation science research to strengthen malaria policy and control in Uganda
-
批准号:9884661
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2017
-
负责人:MATTHEW G DORSEY
-
依托单位:
Training in malaria surveillance, epidemiology and implementation science research to strengthen malaria policy and control in Uganda
-
批准号:10472969
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2017
-
负责人:MATTHEW G DORSEY
-
依托单位:
Training in malaria surveillance, epidemiology and implementation science research to strengthen malaria policy and control in Uganda
-
批准号:9322270
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2017
-
负责人:MATTHEW G DORSEY
-
依托单位:
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
-
批准号:8708770
-
项目类别:
-
资助金额:$52.2万
-
财政年份:2011
-
负责人:MATTHEW G DORSEY
-
依托单位:
Administration
-
批准号:8298674
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2011
-
负责人:MATTHEW G DORSEY
-
依托单位:
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
-
批准号:8333217
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2011
-
负责人:MATTHEW G DORSEY
-
依托单位:
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
-
批准号:8538894
-
项目类别:
-
资助金额:$55.0万
-
财政年份:2011
-
负责人:MATTHEW G DORSEY
-
依托单位:
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
-
批准号:8841111
-
项目类别:
-
资助金额:$20.53万
-
财政年份:2011
-
负责人:MATTHEW G DORSEY
-
依托单位:
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
-
批准号:8627670
-
项目类别:
-
资助金额:$3.7万
-
财政年份:2011
-
负责人:MATTHEW G DORSEY
-
依托单位:
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
-
批准号:9024640
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2011
-
负责人:MATTHEW G DORSEY
-
依托单位:
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
-
批准号:8438355
-
项目类别:
-
资助金额:$17.45万
-
财政年份:2011
-
负责人:MATTHEW G DORSEY
-
依托单位:
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal
-
批准号:10376303
-
项目类别:
-
资助金额:$198.7万
-
财政年份:2010
-
负责人:MATTHEW G DORSEY
-
依托单位:
Administrative Core
-
批准号:10376304
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2010
-
负责人:MATTHEW G DORSEY
-
依托单位:
Chemopreventive therapy for malaria in HIV uninfected children
-
批准号:8133805
-
项目类别:
-
资助金额:$59.07万
-
财政年份:2010
-
负责人:MATTHEW G DORSEY
-
依托单位:
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda
-
批准号:8101220
-
项目类别:
-
资助金额:$179.67万
-
财政年份:2010
-
负责人:MATTHEW G DORSEY
-
依托单位:
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal
-
批准号:9889867
-
项目类别:
-
资助金额:$169.91万
-
财政年份:2010
-
负责人:MATTHEW G DORSEY
-
依托单位:
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda
-
批准号:8298677
-
项目类别:
-
资助金额:$176.44万
-
财政年份:2010
-
负责人:MATTHEW G DORSEY
-
依托单位:
海外基金